Dose Adjustment Considerations in Psychopharmacology
About the Lecture
The lecture Dose Adjustment Considerations in Psychopharmacology by Melissa Kalensky, FNP-BC, PMHNP-BC, CNE is from the course Psychopharmacology Foundations: From Pharmacokinetics to Clinical Practice.
Included Quiz Questions
What is the primary clinical consideration when the half-life of a psychotropic medication is significantly extended in elderly patients?
- Dosing intervals may need to be lengthened to prevent drug accumulation.
- Dosing intervals should be shortened to maintain therapeutic levels.
- The medication should be discontinued immediately due to safety concerns.
- Higher doses are required to achieve the same therapeutic effect.
- Genetic testing becomes mandatory before continuing treatment.
Which advantage makes extended-release formulations particularly beneficial for patients with psychiatric conditions?
- Improved medication adherence through reduced dosing frequency.
- Higher bioavailability compared to immediate-release formulations.
- Faster onset of therapeutic action for acute symptoms.
- Lower cost compared to other medication formulations.
- Elimination of potential side effects seen with other formulations.
Which factor most significantly impacts medication adherence in psychiatric patients according to clinical research?
- Side effects that interfere with daily functioning and quality of life.
- Cost of medications covered by insurance plans.
- Complexity of the pharmacy pickup process.
- Distance from patient's home to the prescribing clinic.
- Availability of generic versions of prescribed medications.
In which clinical scenario would genetic testing be most appropriately implemented for psychotropic medication management?
- When a patient has experienced multiple failed trials with standard dosing.
- Before prescribing any psychotropic medication to any new patient.
- Only when patients specifically request genetic testing services.
- When patients have a family history of any psychiatric condition.
- After patients have been stable on medications for over one year.
These courses may be of interest to you
Author of lecture Dose Adjustment Considerations in Psychopharmacology
Melissa Kalensky, FNP-BC, PMHNP-BC, CNE
Customer reviews
5,0 of 5 stars
| 5 Stars |
|
5 |
| 4 Stars |
|
0 |
| 3 Stars |
|
0 |
| 2 Stars |
|
0 |
| 1 Star |
|
0 |
